Cargando…
Cancer as a Metabolic Disorder
Cancer has long been considered a genetic disease characterized by a myriad of mutations that drive cancer progression. Recent accumulating evidence indicates that the dysregulated metabolism in cancer cells is more than a hallmark of cancer but may be the underlying cause of the tumor. Most of the...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835572/ https://www.ncbi.nlm.nih.gov/pubmed/35163079 http://dx.doi.org/10.3390/ijms23031155 |
_version_ | 1784649466623557632 |
---|---|
author | Gyamfi, Jones Kim, Jinyoung Choi, Junjeong |
author_facet | Gyamfi, Jones Kim, Jinyoung Choi, Junjeong |
author_sort | Gyamfi, Jones |
collection | PubMed |
description | Cancer has long been considered a genetic disease characterized by a myriad of mutations that drive cancer progression. Recent accumulating evidence indicates that the dysregulated metabolism in cancer cells is more than a hallmark of cancer but may be the underlying cause of the tumor. Most of the well-characterized oncogenes or tumor suppressor genes function to sustain the altered metabolic state in cancer. Here, we review evidence supporting the altered metabolic state in cancer including key alterations in glucose, glutamine, and fatty acid metabolism. Unlike genetic alterations that do not occur in all cancer types, metabolic alterations are more common among cancer subtypes and across cancers. Recognizing cancer as a metabolic disorder could unravel key diagnostic and treatments markers that can impact approaches used in cancer management. |
format | Online Article Text |
id | pubmed-8835572 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88355722022-02-12 Cancer as a Metabolic Disorder Gyamfi, Jones Kim, Jinyoung Choi, Junjeong Int J Mol Sci Review Cancer has long been considered a genetic disease characterized by a myriad of mutations that drive cancer progression. Recent accumulating evidence indicates that the dysregulated metabolism in cancer cells is more than a hallmark of cancer but may be the underlying cause of the tumor. Most of the well-characterized oncogenes or tumor suppressor genes function to sustain the altered metabolic state in cancer. Here, we review evidence supporting the altered metabolic state in cancer including key alterations in glucose, glutamine, and fatty acid metabolism. Unlike genetic alterations that do not occur in all cancer types, metabolic alterations are more common among cancer subtypes and across cancers. Recognizing cancer as a metabolic disorder could unravel key diagnostic and treatments markers that can impact approaches used in cancer management. MDPI 2022-01-21 /pmc/articles/PMC8835572/ /pubmed/35163079 http://dx.doi.org/10.3390/ijms23031155 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Gyamfi, Jones Kim, Jinyoung Choi, Junjeong Cancer as a Metabolic Disorder |
title | Cancer as a Metabolic Disorder |
title_full | Cancer as a Metabolic Disorder |
title_fullStr | Cancer as a Metabolic Disorder |
title_full_unstemmed | Cancer as a Metabolic Disorder |
title_short | Cancer as a Metabolic Disorder |
title_sort | cancer as a metabolic disorder |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835572/ https://www.ncbi.nlm.nih.gov/pubmed/35163079 http://dx.doi.org/10.3390/ijms23031155 |
work_keys_str_mv | AT gyamfijones cancerasametabolicdisorder AT kimjinyoung cancerasametabolicdisorder AT choijunjeong cancerasametabolicdisorder |